PROTECT would like to invite members to attend this event. They have some multi-national IVD manufacturers but are particularly keen to attract more companies from within the BIVDA membership. Please contact firstname.lastname@example.org if you would like to attend.
Helen will be delivering a session at the event on an “Update on IVD regulations following Brexit- what industry partners need to know about adoption of IVDs in the NHS”. The draft programme event can be found here.
There will also be a moderated discussion of antimicrobial stewardship diagnostics research and engaging with academic groups to generate evidence.
PROTECT are looking for companies to take part and would like to invite companies to provide a 5-minute pitch about potential products for evaluation in the platform trial.
(Please share only what’s in the public domain about technologies and approach- host response vs pathogen)
- What is the innovation?
- Which part of the pathway does it target?
- How does it improve outcomes (clinical, patient-reported, organisational (staff, resources antimicrobial consumption etc)?
- What published evidence do you have?